Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Hodgkin Disease
×
ruxolitinib
×
Clear all
Filters
3
NCT01965119
2018-11-01
JAK2
Samsung Medical Center
Phase 2
Completed
20 enrolled
NCT01877005
2018-08-22
HIJAK
The Lymphoma Academic Research Organisation
Phase 2
Completed
33 enrolled